e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CG Oncology, Inc. - Common stock
(NQ:
CGON
)
42.98
+1.73 (+4.21%)
Streaming Delayed Price
Updated: 2:31 PM EST, Nov 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
586,180
Open
40.93
Bid (Size)
42.95 (100)
Ask (Size)
43.05 (100)
Prev. Close
41.25
Today's Range
39.34 - 43.06
52wk Range
14.80 - 45.56
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead
↗
November 17, 2025
A science-first biotech fund just sized up its stake in an ALS-focused company heading into a pivotal year for the firm.
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch
↗
November 17, 2025
This biotech-focused fund made a big bet on Liquidia just as the company's YUTREPIA drug notched its first full quarter of commercialization.
Via
The Motley Fool
Topics
Regulatory Compliance
Performance
YTD
+48.4%
+48.4%
1 Month
-1.4%
-1.4%
3 Month
+64.5%
+64.5%
6 Month
+72.9%
+72.9%
1 Year
+29.4%
+29.4%
More News
Read More
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover
↗
November 17, 2025
Via
The Motley Fool
CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 14, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Why Cg Oncology Stock Rocketed 7% Higher Today
↗
October 08, 2025
Via
The Motley Fool
CG Oncology Stock Signals Bullish Momentum Ahead
↗
September 08, 2025
Via
Benzinga
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
September 05, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Completes Enrollment in PIVOT-006
September 03, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
August 29, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Cg Oncology (CGON) Q2 Loss Widens 93%
↗
August 08, 2025
Via
The Motley Fool
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 08, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
July 29, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Which stocks are moving before the opening bell on Tuesday?
↗
July 22, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 22, 2025
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock
↗
July 16, 2025
Via
Benzinga
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
Via
Investor Brand Network
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
Via
FinancialNewsMedia
Topics
Death
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
June 18, 2025
Via
FinancialNewsMedia
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
May 15, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
May 13, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
↗
May 04, 2025
Via
Benzinga
Topics
Artificial Intelligence
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 01, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
These stocks are moving in today's session
↗
April 28, 2025
Via
Chartmill
Frequently Asked Questions
Is CG Oncology, Inc. - Common stock publicly traded?
Yes, CG Oncology, Inc. - Common stock is publicly traded.
What exchange does CG Oncology, Inc. - Common stock trade on?
CG Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for CG Oncology, Inc. - Common stock?
The ticker symbol for CG Oncology, Inc. - Common stock is CGON on the Nasdaq Stock Market
What is the current price of CG Oncology, Inc. - Common stock?
The current price of CG Oncology, Inc. - Common stock is 42.98
When was CG Oncology, Inc. - Common stock last traded?
The last trade of CG Oncology, Inc. - Common stock was at 11/18/25 02:31 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.